What You Should Know:
– Pangea Biomed, a leader in precision oncology, announced a significant breakthrough in its ENLIGHT cancer response predictor. A new study published in Nature Cancer demonstrates the effectiveness of their ENLIGHT-DP…
Continue Reading
What You Should Know:
– A new report by Accenture, “Reinventing R&D in the Age of AI,” paints a clear picture: the biopharmaceutical industry stands at a critical juncture. Companies that embrace intelligent technologies like…
Continue Reading
Gameto, a biotechnology company, has raised $33 million in Series B funding, which it will use to support the clinical development of its in vitro maturation (IVM) product called Fertilo.
New York City-based Gameto develops…
Continue Reading
What You Should Know:
– PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights.
– …
Continue Reading
Here’s part 2 of MedCity News’ Q&A with Astellas Pharma CEO Naoki Okamura who was in South San Francisco last week for the opening of the Japanese pharma company’s West Coast Innovation Center. You…
Continue Reading
A new company emerged out of stealth mode this week at the SynBioBeta conference in San Jose. The startup, called CybergenX, is seeking to integrate AI-powered cybergenetic technology into the synthetic biology field.
The company,…
Continue Reading
Last month, an app named Rejoyn became the first FDA-cleared prescription digital therapeutic for patients with major depressive disorder. The app, which changes users’ behavior through various lessons and exercises, was developed by Otsuka…
Continue Reading
What You Should Know:
· Yseop, a world-leading Artificial Intelligence (AI) software company and pioneer in Generative AI, has announced today the development of an enhanced Generative AI application tailored for the Biopharma industry, with…
Continue Reading
What You Should Know:
– Quest Diagnostics today announced it will acquire key assets of PathAI Diagnostics, including its state-of-the-art digital pathology laboratory in Memphis, Tennessee.
– As part of the acquisition, this facility will become…
Continue Reading
Season 2 of the MedCity Pivot Podcast has launched with a special focus on the evolution of phamacy and pharmacy benefit management. The first guest this season is A.J. Loiacono, who leads Capital Rx,…
Continue Reading
